Literature DB >> 2319481

Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.

E Sanders-Bush1, M Breeding.   

Abstract

This paper tests the hypothesis that spare serotonin 5-HT1c receptors are present in the rat choroid plexus and explores the possible influence of such sites on the adaptive regulation of the 5-HT1c receptor. The consequences of partial receptor inactivation were compared for the natural agonist 5-HT and the putative partial agonists trifluoromethylphenylpiperazine (TFMPP) and (+)-lysergic acid diethylamide (LSD). These studies showed approximately 50% reserve of 5-HT1c receptors in the rat choroid plexus. The calculated KA for 5-HT obtained by partial irreversible inactivation was 36 nM. Phenoxybenzamine reduced the maximum response elicited by TFMPP and LSD, without shifting the EC50 values, consistent with the interpretation that TFMPP and LSD are partial agonist at the 5-HT1c receptor in rat choroid plexus. The KA of TFMPP and LSD was 0.16 microM and 9 nM, respectively. Quantitative analysis of percentage of receptor occupancy vs. percentage of maximum response showed that 5-HT occupied only 70% of the receptors to give a maximum response, whereas a linear relationship between percentage of occupancy and response was found for TFMPP. These differences had functional consequences as demonstrated in studies of regulation of the 5-HT1c receptor. Chronic administration of the 5-HT agonist quipazine produced a 32% loss of 5-HT1c binding sites in the choroid plexus, with no change in the 5-HT-induced phosphoinositide hydrolysis response. This dissociation between binding and function is likely explained by the receptor reserve that exists for the 5-HT1c receptors. Consistent with this interpretation, the TFMPP-induced phosphoinositide hydrolysis signal was reduced to the same extent as the loss of binding sites. These results show that the 5-HT1c receptor in the choroid plexus adapts predictably to chronic receptor activation and suggest the possibility that the paradoxical regulation that has been described for other 5-HT receptors might be explained partially by the unrecognized existence of receptor reserve.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319481

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.

Authors:  Katharine Herrick-Davis; Ellinor Grinde; Barbara A Weaver
Journal:  Eur J Pharmacol       Date:  2007-05-04       Impact factor: 4.432

2.  Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.

Authors:  Katharine Herrick-Davis; Ellinor Grinde; Tara Lindsley; Ann Cowan; Joseph E Mazurkiewicz
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

3.  Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.

Authors:  E Sanders-Bush; M Breeding
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system.

Authors:  S E Swinford-Jackson; N C Anastasio; R G Fox; S J Stutz; K A Cunningham
Journal:  Neuroscience       Date:  2016-02-27       Impact factor: 3.590

5.  Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.

Authors:  E P Pälvimäki; B L Roth; H Majasuo; A Laakso; M Kuoppamäki; E Syvälahti; J Hietala
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

6.  Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.

Authors:  J Benjamin; B D Greenberg; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

7.  Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.

Authors:  D Hommer; P Andreasen; D Rio; W Williams; U Ruttimann; R Momenan; A Zametkin; R Rawlings; M Linnoila
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

8.  The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.

Authors:  A M Brown; T L Patch; A J Kaumann
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

9.  Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase.

Authors:  Joyce H Hurley; Shengwen Zhang; Leighan S Bye; Mark S Marshall; Anna A DePaoli-Roach; Kunliang Guan; Aaron P Fox; Lei Yu
Journal:  BMC Neurosci       Date:  2003-06-09       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.